Literature DB >> 22152619

Significance of human cytomegalovirus and Epstein-Barr virus in inducing cytokine expression in periapical lesions.

Mohammad Sabeti1, Vali Kermani, Sara Sabeti, James H Simon.   

Abstract

INTRODUCTION: Because herpesviruses might be etiologically involved in periapical pathosis of endodontic origin, this study aimed to determine the occurrence of human cytomegalovirus (HCMV), Epstein-Barr virus (EBV), and the expression of mRNA transcripts of tumor necrosis factor (TNF)-α, γ-interferon (IFN), interleukin (IL)-1β, IL-6, IL-12, and IL-10 in periapical granulomatous lesions collected in conjunction with apicoectomy.
METHODS: A total of 9 symptomatic and 6 asymptomatic teeth with periapical lesions were studied. Periapical samples were collected in conjunction with apicoectomy, which was being performed because of radiographic evidence of incomplete periapical healing after conventional root canal therapy. By using established polymerase chain reaction primers and procedures, polymerase chain reaction assays were used to identify herpesvirus and cytokine gene expression.
RESULTS: The difference in occurrence of HCMV, EBV, and cytokines between symptomatic and asymptomatic periapical lesions was statistically significant: HCMV (P = .048), EBV (P = .002), IFN (P = .001), IL-1 (P = .012), IL-6 (P = .026), IL-10 (P = .026), IL-12 (P = .012), and TNF (P < .001) (Mann-Whitney U test). There was a significant correlation between EBV, HCMV, and TNF, γ-IFN, IL-1, and IL-12 in symptomatic periapical lesions (Spearman test).
CONCLUSIONS: The present findings provide evidence of a putative role of HCMV and EBV in the pathogenesis of symptomatic periapical pathosis. The release of tissue-destructive cytokines might be of pathogenetic significance.
Copyright © 2012 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22152619     DOI: 10.1016/j.joen.2011.09.026

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  7 in total

Review 1.  Viruses in pulp and periapical inflammation: a review.

Authors:  Scarlette Hernández Vigueras; Manuel Donoso Zúñiga; Enric Jané-Salas; Luis Salazar Navarrete; Juan José Segura-Egea; Eugenio Velasco-Ortega; José López-López
Journal:  Odontology       Date:  2015-03-22       Impact factor: 2.634

2.  Detection of herpesviruses and human papillomavirus in acute apical abscesses by real-time PCR.

Authors:  Ahmet Ozbek; Selcuk M Ozbek
Journal:  Clin Oral Investig       Date:  2014-05-07       Impact factor: 3.573

Review 3.  A case of age-related Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disorder, so-called polymorphous subtype, of the mandible, with a review of the literature.

Authors:  Kentaro Kikuchi; Shuichi Fukunaga; Harumi Inoue; Yuji Miyazaki; Masaru Kojima; Fumio Ide; Kaoru Kusama
Journal:  Head Neck Pathol       Date:  2012-08-07

4.  Epstein-Barr virus infection in chronically inflamed periapical granulomas.

Authors:  Kosuke Makino; Osamu Takeichi; Keisuke Hatori; Kenichi Imai; Kuniyasu Ochiai; Bunnai Ogiso
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 5.  Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease?

Authors:  Afsar R Naqvi; Jennifer Shango; Alexandra Seal; Deepak Shukla; Salvador Nares
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

6.  Relationship between herpesviruses and periodontal disease progression.

Authors:  Pinar Emecen-Huja; Robert J Danaher; Dolphus R Dawson; Chunmei Wang; Richard J Kryscio; Jeffrey L Ebersole; Craig S Miller
Journal:  J Clin Periodontol       Date:  2020-02-03       Impact factor: 7.478

7.  Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus.

Authors:  Yingxia Liu; Shaoyuan Li; Guoliang Zhang; Guang Nie; Zhizhong Meng; Dongting Mao; Chang Chen; Xinchun Chen; Boping Zhou; Gucheng Zeng
Journal:  BMC Immunol       Date:  2013-08-08       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.